Henry Schein, Inc. (NASDAQ:HSIC) Position Raised by Wealthspire Advisors LLC

Wealthspire Advisors LLC raised its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 5.9% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 15,772 shares of the company’s stock after purchasing an additional 874 shares during the quarter. Wealthspire Advisors LLC’s holdings in Henry Schein were worth $1,091,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently modified their holdings of the company. Versant Capital Management Inc raised its position in Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock worth $32,000 after acquiring an additional 335 shares in the last quarter. Venturi Wealth Management LLC raised its holdings in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock worth $41,000 after purchasing an additional 569 shares in the last quarter. Quent Capital LLC raised its holdings in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company’s stock worth $47,000 after purchasing an additional 323 shares in the last quarter. City State Bank acquired a new stake in Henry Schein during the fourth quarter valued at approximately $55,000. Finally, Farther Finance Advisors LLC boosted its holdings in Henry Schein by 58.9% during the third quarter. Farther Finance Advisors LLC now owns 933 shares of the company’s stock worth $68,000 after buying an additional 346 shares in the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

Shares of HSIC opened at $77.64 on Tuesday. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. The company has a market capitalization of $9.68 billion, a price-to-earnings ratio of 31.95, a P/E/G ratio of 2.13 and a beta of 0.91. The business’s 50-day moving average is $74.19 and its 200-day moving average is $72.38. Henry Schein, Inc. has a fifty-two week low of $63.67 and a fifty-two week high of $82.63.

Analyst Ratings Changes

A number of equities research analysts have recently commented on the company. StockNews.com upgraded Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. Barrington Research upped their target price on Henry Schein from $82.00 to $90.00 and gave the company an “outperform” rating in a report on Thursday, January 30th. Wells Fargo & Company started coverage on Henry Schein in a research report on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Mizuho assumed coverage on Henry Schein in a report on Wednesday, December 4th. They set a “neutral” rating and a $75.00 price objective on the stock. Finally, Jefferies Financial Group raised their target price on shares of Henry Schein from $77.00 to $80.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. Eight research analysts have rated the stock with a hold rating, five have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $80.09.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.